Disclosure Dr. Mendoza reports receiving speaker fees and honoraria from AstraZeneca, Roche, Hi-Eisai, and Zuellig Pharma outside of the current work. Dr. Mendoza is a board member of the Sagip Buhay Medical Foundation and chair of the committee on continuing professional development of the Philippine College of Physicians. Dr. DB Sacdalan reports receiving honorarium from the Department of Science and Technology and Philippine Council of Health Research and Development of the Republic of the Philippines outside of the current work. Dr. Samala reports receiving speaker fees and honorarium from Hi-Esai and the Surgical Oncology Society of the Philippines outside of the current work. Dr. Samala is the incumbent Vice-President, Philippine Society of Oncologists. Dr. Lui reports receiving consulting fees from AstraZeneca, Pfizer, Merck, Merck Sharp & Dohme, Novartis, Takeda, Eli Lilly, Amgen, Johnson & Johnson, Roche, and Hi-Eisai outside of the current work. Dr. Lui reports receiving speaker fees and honorarium from AstraZeneca, Pfizer, Merck, Merck Sharp & Dohme, Novartis, Takeda, Eli Lilly, Amgen, Johnson & Johnson, Roche, Guardant, Taiho, and Sandoz outside of the current work. Dr. Lui reports receiving educational grants from Pfizer and AstraZeneca. Dr. Lui reports receiving travel and conference registration support from AstraZeneca, Merck, Merck Sharp & Dohme, Pfizer, and Takeda. Dr. Imasa reports receiving speaker fees from AstraZeneca, Pfizer, Roche, Johnson & Johnson, Takeda, Hi-Esai, Merck Sharp & Dohme, and Sandoz outside of the current work. Dr. Imasa reports receiving travel and conference registration support from AstraZeneca, Camber, Merck Sharp & Dohme, and Sun Pharma. Dr. Sagpao reports receiving speaker fees and honorarium from Bayer outside of the current work. Dr. DL Sacdalan reports receiving speaker fees and honorarium from Amgen, Roche, Pfizer, Gene Solution, and Merck Sharp & Dohme outside of the current work. Dr. DL Sacdalan reports receiving travel and conference registration support from Unilab.